EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieKlinische Studie (Phase III)KohortenstudieOpen Access

Medication Adherence Behavior Assessed Using a Digital Bottle Cap: Retrospective Cohort Study

Andrzej Nowojewski iD, Olga Elizarova iD, Annika Rutgersson iD, Anna Zarodkiewicz iD, Yunyun Jiang iD, Anneli Olsson iD, Matthew Kelham iD, Jessica Hanson iD, David Austin iD, Daniel A Jones iD, Ehsan Parvaresh Rizi iD, Wilhelm Ridderstråle iD und 3 weitere

Journal of Medical Internet Research · 2026

DOI: 10.2196/91299 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Medical Internet Research, 2026. Verfasst von Andrzej Nowojewski und 14 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Pharmacology and Safety Sciences, Biopharmaceutical Research and Development, AstraZeneca, Cambridge, England, United Kingdom. Hauptthemen laut MEDLINE: Myocardial Infarction, Medication Adherence, Drug Monitoring, Drug Packaging. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Medication nonadherence in patients with myocardial infarction (MI) is a key obstacle to managing cardiovascular disease. However, there is a lack of studies, particularly randomized controlled trials (RCTs), focusing on objective measures of medication adherence behavior.

Objective

This study aimed to (1) characterize daily medication adherence behavior and dose consistency using objective digital bottle cap data in patients post-MI enrolled in the Dapagliflozin in Patients with Myocardial Infarction (DAPA-MI) RCT, (2) identify patient and contextual factors associated with nonadherence, and (3) assess whether dose consistency is associated with adherence over time.

Methods

DAPA-MI was a phase 3, double-blind, placebo-controlled RCT evaluating the effect of 10 mg of dapagliflozin versus a placebo given once daily, in addition to standard-of-care therapy, on adults hospitalized for MI. This post hoc analysis used 733,490 timepoints from a digital bottle cap that recorded when study drug bottles were opened. Adherence and dose consistency were evaluated using mixed-effects regression. Adherence was defined at the patient-day level as at least one bottle opening on a given day. Dose consistency was derived from the day-to-day variation in timing of the first recorded opening event. Digital cap data were linked with demographic, clinical, behavioral, and contextual variables to assess factors associated with nonadherence and lower dose consistency over time.

Results

In total, 2429 participants were included in the analysis. Features associated with lower adherence included age

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocardial InfarctionMedication AdherenceDrug MonitoringDrug PackagingHumansRetrospective StudiesFemaleMiddle AgedMaleAgedDouble-Blind MethodBenzhydryl CompoundsGlucosides

Stichwörter der Autor:innen

DAPA-MIDapagliflozin in Patients with Myocardial Infarctionacute myocardial infarctionadherence behaviorconnected devicecontinuous monitoringdigital healthhabitmedication adherenceremote monitoringsmart bottle

Substanzen

Benzhydryl CompoundsGlucosides

Autor:innen und Institutionen

  • Clinical Pharmacology and Safety Sciences, Biopharmaceutical Research and Development, AstraZeneca, Cambridge, England, United Kingdom.
  • Digital Health Oncology Research and Development, AstraZeneca, Waltham, MA, United States.
  • Evinova, AstraZeneca, Mölndal, Sweden.
  • Clinical Operations, Biopharmaceutical Research and Development, AstraZeneca, Warsaw, Poland.
  • Biometrics, Late-stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals Research & Development, AstraZeneca, Gaithersburg, MD, United States.
  • Division of Cardiology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.

ORCID-Profile: Andrzej Nowojewski, Olga Elizarova, Annika Rutgersson, Anna Zarodkiewicz, Yunyun Jiang, Anneli Olsson, Matthew Kelham, Jessica Hanson, David Austin, Daniel A Jones, Ehsan Parvaresh Rizi, Wilhelm Ridderstråle, Jonas Oldgren, Stefan James, Robert F Storey

Zitieren

APA

Nowojewski, A., Elizarova, O., Rutgersson, A., Zarodkiewicz, A., Jiang, Y., Olsson, A., Kelham, M., Hanson, J., Austin, D., Jones, D. A., Parvaresh Rizi, E., Ridderstråle, W., Oldgren, J., James, S., & Storey, R. F. (2026). Medication Adherence Behavior Assessed Using a Digital Bottle Cap: Retrospective Cohort Study. Journal of Medical Internet Research. https://doi.org/10.2196/91299

Vancouver

Nowojewski A, Elizarova O, Rutgersson A, Zarodkiewicz A, Jiang Y, Olsson A, et al. Medication Adherence Behavior Assessed Using a Digital Bottle Cap: Retrospective Cohort Study. Journal of Medical Internet Research. 2026. doi:10.2196/91299

BibTeX
@article{Nowojewski2026,
  author = {Nowojewski, Andrzej and Elizarova, Olga and Rutgersson, Annika and Zarodkiewicz, Anna and Jiang, Yunyun and Olsson, Anneli and Kelham, Matthew and Hanson, Jessica and Austin, David and Jones, Daniel A and Parvaresh Rizi, Ehsan and Ridderstråle, Wilhelm and Oldgren, Jonas and James, Stefan and Storey, Robert F},
  title = {Medication Adherence Behavior Assessed Using a Digital Bottle Cap: Retrospective Cohort Study},
  journal = {Journal of Medical Internet Research},
  year = {2026},
  doi = {10.2196/91299}
}
Kostenlos starten →